Fingerprint
Dive into the research topics of 'BCR-ABL kinase domain mutations in chronic myeloid leukemia: Not quite enough to cause resistance to imatinib therapy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
BCR-ABL kinase domain mutations in chronic myeloid leukemia: Not quite enough to cause resistance to imatinib therapy?
Thoralf Lange, Byung Park, Stephanie G. Willis, Michael W.N. Deininger
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations